Questex’s Fierce Life Sciences Announces 2025 Innovation Awards Winners
Showcases the Outstanding Innovation Driving Improvements and Transforming the Life Sciences Industry; Unveils Innovation Report that Feature Winners
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech and Fierce Pharma today announce the winners of the Fierce Life Sciences Innovation Awards. The program showcases outstanding innovation that is driving improvements and transforming the life sciences industry.
“Technology is reshaping every corner of our industry — from AI to powerful new ways of harnessing data. This year’s winners represent the bold vision and innovation leading that charge. We’re thrilled to celebrate these pioneers and the momentum they’re creating. Congratulations to the 2025 winners,” says Rebecca Willumson, SVP and Publisher of Fierce Biotech and Fierce Pharma.
2025 Fierce Life Sciences Innovation Awards winners:
- AI Innovation: Immunai - Immunai Platform (AMICA™, CT-OS™, PE-OS™)
- Biotech Innovation: Orca Bio - Orca-T® allogeneic T-cell immunotherapy
- Data Analytics/Business Intelligence: Domino Data Lab - Domino for Life Sciences
- Digital Health Solutions: DrFirst - Timely by DrFirst
- Drug Delivery Technology: Entrada Therapeutics - Endosomal Escape Vehicle (EEV™) Platform
- Medical Device Innovation: ATED Therapeutics Ltd. - Parkinson Disease Rapid Blood Diagnostic Test
- Operations Solutions: Danaher Corporation - Personalized CRISPR Therapy Platform
- Technology Innovation: SandboxAQ - AQBioSim
An expert panel of judges reviewed the hundreds of awards submissions and determined which companies demonstrated innovative technologies and services that have the greatest potential to create efficiencies, engage patients, or revolutionize the industry.
Winners are featured in the Life Sciences Innovation Report. Click here to read the report.
Winners will also be honored during the Fierce 50 Awards Gala. Learn more about the Gala and register to attend here.
About Fierce Biotech
Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here.
About Fierce Pharma
Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Pharma for the latest news, analysis and data on drugs and the companies that make them. Fierce Pharma covers the pharma waterfront, from late-stage drug development through the entire lifecycle— tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Pharma team produces special reports that take stock of the industry’s products and finances, and shed new light on industry trends.
About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.
Media Contact
Linda Lam
Director of Marketing, Life Sciences and Healthcare
llam@questex.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
